Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Dotinurad in Hyperuricemia With Hypertension: a Randomized Study With Febuxostat (DIANA-NEXT)

NCT06834230 is registered in ClinicalTrials.gov with Saga University as lead sponsor.

NCT NCT06834230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06834230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Dotinurad in Hyperuricemia With Hypertension: a Randomized Study With Febuxostat (DIANA-NEXT)
Lead sponsor
Saga University
Phase
Phase 4
Overall status
Recruiting
Start date
March 28, 2025
Completion date
March 31, 2030
Enrollment
360 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, hyperuricemia or gout